High levels of sTNFR p75 and TNFα in dengue-infected patients

Microbiology and Immunology

Volumn 40, Issue 8, 1996, Pages 569-573

  Hober, Didier ^a,c   Delannoy, Anne Sophie ^a   Benyoucef, Samira ^a   De Groote, Donat ^b   Wattré, Pierre ^a  

^a CHU Rouen BG   (France)

^b Medgenix Diagnostics SA   (Belgium)

^c Laboratoire de Biologie Polyvalente   (French Polynesia)

Author keywords

Dengue; Patients; sTNFR p75; TNF

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DENGUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EPIDEMIC; HUMAN; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYNESIA; WORLD HEALTH ORGANIZATION;

EID: 0029787535     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb01110.x     Document Type: Article

References (36)

1. Aderka, D., Engelmann, H., Hornik, V., Skornick, Y, Levo, Y, Wallach, D., and Kushtai, G. 1991. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res. 51: 5602-5607.
2. Aderka, D., Engelmann, H., Maor, Y, Brakebusch, C., and Wallach, D. 1992. Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors. J. Exp. Med. 175: 323-329.
3. Aderka, D., Engelmann, H., Shemer-Avni, Y, Hornik, V., Galil, A., Sarov, B., and Wallach, D. 1992. Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res. 11: 157-159.
4. Aukrust, P., Liabakk, N.B., Müller, R, Lien, E., Espevik, T., and Froland, S. 1994. Serum levels of tumor necrosis factor-α (TNFα) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169: 420-424.
5. Balkwill, F., Burke, F., Talbot, D., Tavernier, J., Osborne, R., Naylor, S., Durbin, H., and Fiers, W. 1987. Evidence for tumor necrosis factor/cachectin production in cancer. Lancet ii: 1229-1232.
6. Beutler, B., and Cerami, A. 1988. Tumor necrosis, cachexia, shock and inflammation: a common mediator. Annu. Rev. Biochem. 57: 505-518.
7. Chungue, E., Spiegel, A., Philippon, G., Laudon, F., Cardines, R., and Roux, J. 1990. Dengue and dengue haemorrhagic fever in french polynesia: a comparative study of 2 successive epidemics. Southeast Asian J. Trop. Med. Public Health 21: 680-681.
8. Cohen, S.N., and Halstead, S.B. 1966. Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand. J. Pediat. 68: 448-456.
9. Engelberts, I., Moller, A., Schoen, G.J.M., Vanderlinden, C.J., and Buurman, W.A. 1991. Evaluation of measurement of human TNF in plasma by Elisa. Lymphokine Cytokine Res. 10: 69-76.
10. Foley, N., Lambert, C., McNicol, M., Johnson, N., and Rook, G.A.W. 1990. An inhibitor of the toxicity of tumor necrosis factor in the serum of patients with sarcoïdosis, tuberculosis and Crohn's disease. Clin. Exp. Immunol. 80: 395-399.
11. Godfried, M.H., Van der Poll, T., Jansen, J., Romijin, J.A., Eeftinck Schattenkerk, J.K.M., Endert, E., Van Deventer, S.J.H., and Sauerwein, H.P. 1993. Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7: 33-36.
12. Halstead, S.B. 1989. Antibody, macrophages, dengue virus infection, shock and hemorrhage: a pathogenic cascade. Rev. Infect. Dis. 11 (Suppl. 4): S830-839.
13. Hober, D., Haque, A., Wattré, P., Beaucaire, G., Mouton, Y., and Capron, A. 1989. Production of tumor necrosis factor alpha (TNF-α) and interleukin 1 (IL-1) in patients with AIDS. Enhanced level of TNF is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78: 329-333.
14. Hober, D., Ajana, F., Petit, M.C., Sartiaux, C., Boniface, M., Caillaux, M., Mouton, Y., Wattré, P., and Maniez-Montreuil, M. 1993. Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha in patients with human immunodeficiency virus (HIV) type 1 infection. Microbiol. Immunol. 37: 785-792.
15. Hober, D., Poli, L., Roblin, B., Gestas, P., Chungue, E., Granic, G., Imbert, P., Pecarere, J.L., Vergez-Pascal, R.,Wattre, P., and Maniez-Montreuil, M. 1993. Serum levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in dengue-infected patients. Am. J. Trop. Med. Hyg. 48: 324-331.
16. Kalinkovich, A., Engelmann, H., Harpaz, N., Burstein, R., Barak, V., Kalickman, I., Wallach, D., and Bentwich, Z. 1992. Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin. Exp. Immunol. 89: 351-355.
17. Kern, P., Hemmer, C.J., Gallati, H., Neifer, S., Kremsner, P., Dietrich, M., and Porzsolt, F. 1992. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J. Infect. Dis. 166: 930-934.
18. Kuno, G.E., and Bailey, R. 1994. Cytokine responses to dengue infection among puerto rican patients. Mem. Instit. Oswaldo Cruz 89: 179-182.
19. Kurane, I.L., Innis, B., Nimmannitya, S., Nisalak, A., Meager, A., Janus, J., and Ennis, F.A. 1991. Activation of T lymphocytes in dengue virus infections, high levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and Interferon γ in sera of children with dengue. J. Clin. Invest. 88: 1473-1480.
20. Kurane, I., and Ennis, F.A. 1994. Cytokines in dengue virus infections: role of cytokines in the pathogenesis of dengue hemorrhagic fever. Sem. Virol. 5: 443-448.
21. Lantz, M., Malik, S., Slevin, M.L., and Olsson, I. 1990. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 2: 406-410.
22. Moller, B., Mogensen, S.C., Wendelboe, P., Bendtzen, K., and Petersen, C.M. 1991. Bioactive and inactive forms of tumor necrosis factor α in spinal fluid from patients with meningitis. J. Infect. Dis. 163: 886-889.
23. Pandita, R., Pocsik, E., and Aggarwal, B.B. 1992. Interferon γ induces cell surface expression for both types of tumor necrosis factor receptors. FEBS Lett. 312: 87-90.
24. Pang, T. 1987. Pathogenesis of dengue haemorrhagic fever: towards a more balanced view. Southeast Asian J. Trop. Med. Public Health 18: 321-325.
25. Seckinger, P., Isaaz, S., and Dayer, J.M. 1988. A human inhibitor of TNF. J. Exp. Med. 167: 1511-1516.
26. Seckinger, P., Isaaz, S., and Dayer, J.M. 1989. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J. Biol. Chem. 264: 11966-11973.
27. Suvatte, V. 1987. Immunological aspect of dengue haemorrhagic fever: studies in Thailand. Southeast Asian J. Trop. Med. Public Health 18: 312-315.
28. Tracey, K.J., Lowry, S.F., and Cerami, A. 1988. Cachectin: a hormone that triggers acute shock and chronic cachexia. J. Infect. Dis. 157: 413-420.
29. Van der Poll, T., Vanleenen, D., Vondermohlen, M., Levi, M., Tencate, H., Gallati, H., Tencate, J.W., and Vandeventer, J.H. 1993. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J. Infect. Dis. 168: 955-960.
30. Vitarana, T., De Silva, H., Withana, N., and Gunasekera, C. 1991. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever. Ceylon Med. J. 36: 63-65.
31. Von Asmuth, E.I.U., Maessen, J.G., Van der Linden, C.J., and Buurman, W.A. 1990. Tumor necrosis factor alpha (TNF-α) and interleukin 6 in a zymosan induced shock model. Scand. J. Immunol. 32: 313-319.
32. Wallach, D., Aderka, D., Rubinstein, M., Engelmann, H., Shemer, Y.S., Sarou, I., and Holtmann, H. 1990. Mechanisms involved in regulation of the response to tumor necrosis factor, p 146-155. In Bonavida, B., and Granger, G. (eds), Tumor necrosis factor: structure, mechanism of action, role in disease and therapy, Karger, Basel.
33. World Health Organization. 1980. Technical advisory committee on dengue hemorrhagic fever for southeast Asian Western Pacific regions, guide for diagnosis, treatment and control of dengue hemorrhagic fever, Geneva.
34. Yadav, M., Kamath, K.R., Iyngkaran, N., and Sinniah, M. 1991. Dengue hemorrhagic fever and dengue shock syndrome: are they tumor necrosis factor-mediated disorders? FEMS Microbiol. Immunol. 4: 45-49.
35. Zangerle, R., Gallati, H., Sarcletti, M., Weiss, G., Denz, H., Wachter, H., and Fuchs, D. 1994. Increased serum concentrations of soluble tumor necrosis factor receptors in HIV-infected individuals are associated with immune activation. J. AIDS 7: 79-85.
36. Zijlstra, E.E., van der Poll, T., and Mevissen, M. 1995. Soluble receptors for tumor necrosis factor as markers of disease activity in visceral leishmaniasis. J. Infect. Dis. 171: 498-501.